These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4989519)

  • 1. Tubercle bacilli resistance to cycloserine.
    Zierski M; Rózewska M; Woźniak S
    Scand J Respir Dis Suppl; 1970; 71():291-5. PubMed ID: 4989519
    [No Abstract]   [Full Text] [Related]  

  • 2. [Resistance of tubercle bacilli to cycloserine, viomycin and ethionamide in patients suffering from pulmonary tuberculosis].
    Srednicka-Zajac D; Mysakowska H; Szarewicz-Adamczyk W; Litwin B
    Ann Univ Mariae Curie Sklodowska Med; 1967; 22():71-8. PubMed ID: 4308440
    [No Abstract]   [Full Text] [Related]  

  • 3. [Criteria of clinical resistance of cycloserine, ethionamide and ethambutol].
    Okamoto K; Watanabe S; Terunuma K
    Kekkaku; 1970 Feb; 45(2):65-72. PubMed ID: 4985702
    [No Abstract]   [Full Text] [Related]  

  • 4. [Research for resistance media to Cycloserine. II. The influences of the preservative method of media and the preservative period on the minimal inhibitory concentration of Cycloserine to Mycobacterium tuberculosis].
    Tamura M; Takano S
    Iryo; 1966 Jun; 20(6):573-8. PubMed ID: 4960848
    [No Abstract]   [Full Text] [Related]  

  • 5. [The proportion method of determination of the resistance of tubercle bacilli to ethionamide, cycloserine and viomycin].
    Zduńczyk-Pawelek H
    Gruzlica; 1966 Mar; 34(3):255-63. PubMed ID: 4287801
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on tubercle bacilli resistant to secondary drugs in the resected specimens and sputum of pulmonary tuberculosis patients].
    Kameda K; Kudo S; Iwai K; Ushikubo K
    Kekkaku; 1970 Sep; 45(9):283-7. PubMed ID: 4989932
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on the susceptibility of secondary anti-tuberculosis drugs (with special reference to the resistance-stabilities of cycloserine and ethionamide-resistant bacilli)].
    Hayashi S
    Kumamoto Igakkai Zasshi; 1970 Feb; 44(2):135-43. PubMed ID: 4986047
    [No Abstract]   [Full Text] [Related]  

  • 8. [Restoration of drug sensitivity in Mycobacterium tuberculosis to streptomycin and isoniazid during treatment with preparations of the 1st series].
    Rudoĭ NM; Utkin VV; Fedorova IE; Afanas'eva IuP
    Antibiotiki; 1970 Apr; 15(4):355-7. PubMed ID: 4993044
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sulfa-resistant tubercle bacilli isolated from the sputum of tuberculous patients].
    Ogawa M
    Saishin Igaku; 1966 Jul; 21(7):1592-5. PubMed ID: 4961192
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on media for testing resitance to cycloserine. 4. Various lots of cycloserine and the minimal inhibitory concentration to Mycobacterium tuberculosis].
    Tamura M; Takano S
    Iryo; 1967 May; 21(5):550-2. PubMed ID: 4965697
    [No Abstract]   [Full Text] [Related]  

  • 11. [Suitable pH region for resistance test of cycloserine and for the growth of Mycobacterium tuberculosis].
    Tamura M; Takano S
    Kekkaku; 1966 Nov; 41(11):517-23. PubMed ID: 4962768
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the effect of cycloserine and kanamycin on Mycobacterium tuberculosis (bacteriological and electron microscopic study)].
    Chertkova EI
    Probl Tuberk; 1965; 43(9):57-62. PubMed ID: 4958492
    [No Abstract]   [Full Text] [Related]  

  • 13. Original and efficient synthesis of D-cycloserine.
    Li X; Meng X; Duan H; Wang L; Wang S; Zhang Y; Qin D
    Arch Pharm (Weinheim); 2010 Aug; 343(8):473-5. PubMed ID: 20803624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical activity of cycloserine in the treatment of tuberculosis.
    Perfeito JB
    Scand J Respir Dis Suppl; 1970; 71():180-8. PubMed ID: 5271983
    [No Abstract]   [Full Text] [Related]  

  • 15. [Influence of pH of media on the minimal inhibitory concentration of cycloserine to Mycobacterium tuberculosis].
    Tamura M; Takano S
    Kekkaku; 1965 Jun; 40(6):213-8. PubMed ID: 4955433
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical experience with cycloserine in Hungary.
    Kováts F
    Scand J Respir Dis Suppl; 1970; 71():133-8. PubMed ID: 5271973
    [No Abstract]   [Full Text] [Related]  

  • 17. [Attempt at intermittent chemotherapeutic treatment of patients with bacilli resistant to streptomycin and isoniazid (cooperative survey by the antitubercular services of Marrakech, Meknes, Tangiers)].
    Burzoni FJ; Chicou FJ; Durante C; Hetrick G; Ras R
    Rev Tuberc Pneumol (Paris); 1969 Nov; 33(7):975-86. PubMed ID: 5403000
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug resistance of tubercle bacilli isolated from sputum in previously untreated pulmonary tuberculosis. 3].
    Nakai H; Maekawa N; Nakanishi M; Kawai M; Naito M
    Bull Chest Dis Res Inst Kyoto Univ; 1971 Jan; 4(1):15-24. PubMed ID: 5005481
    [No Abstract]   [Full Text] [Related]  

  • 19. Resistance to cycloserine.
    Kreis B
    Scand J Respir Dis Suppl; 1970; 71():266-78. PubMed ID: 4989517
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on drug resistance test medium of cycloserine. i. Comparison of the minimal intercepting concentrations of Mycobacterium tuberculosis on 1 percent Ogawa medium, Kirchner agar and Kirchner semi-solid agar medium].
    Tamura M; Igai S; Takano S
    Iryo; 1966 Jan; 20(1):71-5. PubMed ID: 4957725
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.